A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy

T-cell-based immunotherapy strategies have profoundly improved the clinical management of several solid tumors and hematological malignancies. A recently developed and promising immunotherapy approach is to redirect polyclonal MHC-unrestricted T lymphocytes toward cancer cells by bispecific antibodi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Satta, Alessandro, Grazia, Giulia, Caroli, Francesco, Frigerio, Barbara, Di Nicola, Massimo, Raspagliesi, Francesco, Mezzanzanica, Delia, Zaffaroni, Nadia, Gianni, Alessandro Massimo, Anichini, Andrea, Figini, Mariangela
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823250/
https://ncbi.nlm.nih.gov/pubmed/31708930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02514
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires